After practicing psychiatry for 40 years, I started feeling like I had seen and heard it all. Thousands of patients had come to my office seeking relief from depression, anxiety, and related disorders ...

New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix&reg ...

ESTERO, FLORIDA / ACCESS Newswire / January 20, 2026 / Aspire Biopharma Holdings, Inc. (ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug ...

ESTERO, FLORIDA - Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) announced Tuesday it has filed a provisional patent application with the U.S. Patent and Trademark Office for a sublingual powder ...

Bial has introduced a new sublingual formulation of apomorphine in the UK, offering a fresh treatment option for adults with Parkinson’s disease who experience intermittent OFF episodes that are not ...

VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

ESTERO, FLORIDA - Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP), a micro-cap biotech company with a market capitalization of $19 million, announced Monday it has filed an omnibus patent application ...

TxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping of platelets that leads to dangerous blood clots This rapid inhibition is critical during suspected heart attacks, ...

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in more than 15 years. (HealthDay News) — The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine ...

The U.S. Food and Drug Administration has approved Tonmya (cyclobenzaprine hydrochloride) sublingual tablets for the treatment of fibromyalgia in adults. The approval is the first for a fibromyalgia ...